BIOMARIN PHAR. DL-,001 financial statements, including revenue, expenses, profit, and loss

The total revenue of BM8 for the last quarter is 600.86 M EUR, and it's 2.68% higher compared to the previous quarter. The net income of Q1 24 is 82.17 M EUR.